RxDoctor Payments Data

Thomas Pollock, DO

Otolaryngology · Hazle Township, PANPI 1134120025

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by GSK at 26.4% of the total. 2025 is the largest year on record at $181, more than ten times the $16 reported in 2020. That places this record below the midpoint for otolaryngology clinicians in PA, where the typical reported total is $881.

$463in general payments, 2019–2025

Across 19 payments — averaging $24.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$122
  • Inspire Medical Systems, Inc.$109
  • Aerin Medical Inc.$92
  • Regeneron Healthcare Solutions, Inc.$55
  • Johnson & Johnson$34
  • Sanofi$20
  • plus $31 from 2 others

What the payments were for

  • Food & beverage$463100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$463 in reported general payments places this provider in the 35th percentile of 456 otolaryngology providers in Pennsylvania.

See all otolaryngology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$114,421
Medicare patients
532
Services billed
2,693

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate257$3,109
Mometasone Furoate30$2,508
Fluocinolone Acetonide Oil23$1,171
Famotidine74$887
Esomeprazole Magnesium26$787
Omeprazole74$685
Methylprednisolone98$684
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort13$644
Azelastine Hcl13$504
Ofloxacin12$482
Ipratropium Bromide16$437
Levocetirizine Dihydrochloride12$229
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid13$203
Pantoprazole Sodium26$125
Amoxicillin36$112

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Hazle Township

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →